Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastoma

Medical and Pediatric Oncology

Volumn 36, Issue 1, 2001, Pages 20-23

  Lastowska M ^a   Van Roy, N ^b   Bown, N ^a   Speleman, F ^b   Roberts, P ^c   Lunec, J ^a   Strachan, T ^a   Pearson, A D J ^a   Jackson, M S ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

17q translocation breakpoints; Neuroblastoma

Indexed keywords

CHROMOSOME 17Q; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CHROMOSOME MAP; CHROMOSOME TRANSLOCATION 17; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; NEUROBLASTOMA; PRIORITY JOURNAL;

CHROMOSOME BREAKAGE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; DNA PROBES; GENE DOSAGE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NEUROBLASTOMA; PROGNOSIS; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0035169983     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-911X(20010101)36:1<20::AID-MPO1006>3.0.CO;2-E     Document Type: Article

References (22)

1. Amplification of Nmyc in untreated human neuroblastomas correlates with advanced disease stage
2. Chromosomal aberration in human neuroblastomas
3. Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma
4. Prognostic factors in neuroblastoma: Clinical, histipathologic, immunocytochemical features and DNA ploidy in relation to prognosis
5. 1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines
6. Additional copies of a 25 Mb chromosomal region originating from 17q23.1-17qter are present in 90% of high-grade neuroblastomas
7. Promiscuous translocations of chromosome arm 17q in human neuroblastomas
8. Comparative genomic hybridization (CGH) analysis of neuroblastomas - An important methodological approach in paediatric tumor pathology
9. Comparative genomic hybridization study of primary neuroblastoma tumors
10. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization
11. Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma
12. Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients
13. Molecular cytogenetic analysis of a complex t(10;11;22) translocation in Ewing's sarcoma
14. Cytogenetic abnormalities of small round cell tumours
15. Molecular cytogenetic analysis of 1;17 translocations in neuroblastoma
16. Recurrent 1:17 translocations in human neuroblastoma reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity
17. High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification
18. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas
19. nm23-H1 mutation in neuroblastoma
20. A nucleoside diphosphate kinase A (nm23-H1) serine 120→glycine substitution in advanced stage neuroblastoma affects enzyme stability and alters protein-protein interaction
21. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
22. A physical map and candidate genes in the BRCA1 region on chromosome 17q12-21